Latest / Dayton News Today | 2 Min News | The Daily News Now!
FDA Panel Votes to Allow Controversial Peptides | Dayton News
The FDA’s Pharmacy Compounding Advisory Committee narrowly voted to allow compounding pharmacies to use certain peptides like BPC-157 and TB-500—claimed to heal wounds or fix gut issues—despite FDA scientists warning there’s insufficient proof of safety or effectiveness. While supporters argue regulated access could prevent dangerous gray-market purchases, critics fear the move could mislead the public into thinking these unproven substances are endorsed or safe, especially since some products may even be mislabeled or contaminated. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.